Pages that link to "10 CFR 35.100, Use of Unsealed Byproduct Material for Uptake, Dilution, and Excretion Studies for Which a Written Directive Is Not Required"
Jump to navigation
Jump to search
The following pages link to 10 CFR 35.100, Use of Unsealed Byproduct Material for Uptake, Dilution, and Excretion Studies for Which a Written Directive Is Not Required:
Displayed 50 items.
- 10 CFR 35.100 (redirect page) (← links)
- 10 CFR 35 (← links)
- RIS 2002-23, Availability of Licensing Guide for Diagnostic Nuclear Medicine (← links)
- ML18043A181 (← links)
- ML18016A679 (← links)
- Regulatory Guide 10.8 (← links)
- ML18096A550 (← links)
- ML18085A070 (← links)
- ML18085A062 (← links)
- ML18061A126 (← links)
- ML18026A641 (← links)
- ML18222A487 (← links)
- ML18234A416 (← links)
- ML18232A434 (← links)
- ML18232A389 (← links)
- ML18226A161 (← links)
- ML18220B372 (← links)
- ML18220A823 (← links)
- ML18218A515 (← links)
- ML18218A513 (← links)
- ML18215A391 (← links)
- ML18215A389 (← links)
- ML18215A354 (← links)
- ML18212A331 (← links)
- ML18212A330 (← links)
- ML18212A059 (← links)
- ML18212A057 (← links)
- ML18212A055 (← links)
- ML18212A053 (← links)
- ML18212A051 (← links)
- ML18211A550 (← links)
- ML18211A446 (← links)
- ML18208A374 (← links)
- ML18208A241 (← links)
- ML18207A655 (← links)
- ML18206A774 (← links)
- ML18206A279 (← links)
- ML18206A272 (← links)
- ML18205A639 (← links)
- ML18205A536 (← links)
- ML18204A412 (← links)
- ML18204A369 (← links)
- ML18201A501 (← links)
- ML18201A417 (← links)
- ML18201A119 (← links)
- ML18198A333 (← links)
- ML18198A069 (← links)
- ML18198A067 (← links)
- ML18198A065 (← links)
- ML18198A063 (← links)
- ML18197A274 (← links)
- ML18194A934 (← links)
- ML18194A835 (← links)
- ML18193B052 (← links)
- ML18193B050 (← links)
- ML18193A513 (← links)
- ML18192C086 (← links)
- ML18191B082 (← links)
- ML18186A517 (← links)
- ML18176A377 (← links)
- ML18176A094 (← links)
- ML18248A022 (← links)
- ML18082A687 (← links)
- ML18071A175 (← links)
- ML18067A249 (← links)
- ML18051A725 (← links)
- ML17360A213 (← links)
- ML003739383 (← links)
- ML003739377 (← links)
- ML18284A028 (← links)
- ML18253A164 (← links)
- ENS 53731 (← links)
- IR 05000232/2014001 (← links)
- ML19039A113 (← links)
- ML18360A626 (← links)
- ML19032A126 (← links)
- ML19016A330 (← links)
- ML19067A254 (← links)
- ML19066A122 (← links)
- ML19058A598 (← links)
- ML19050A141 (← links)
- ML19077A112 (← links)
- ML19063B164 (← links)
- NUREG-0090 Volume 40, Report to Congress on Abnormal Occurrences - Fiscal Year 2017. (← links)
- NUREG-1556 Volume 21, Rev. 1, Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Possession Licenses for Production of Radioactive Material Using an Accelerator - Final Report. (← links)
- ML19115A407 (← links)
- ML19114A546 (← links)
- ML19050A468 (← links)
- ML18263A257 (← links)
- ML18260A255 (← links)
- ML18227A115 (← links)
- ML18227A095 (← links)
- ML19170A337 (← links)
- ML19219B042 (← links)
- ML19106A367 (← links)
- ML19099A410 (← links)
- SECY-19-0024, VR-SECY-19-0024: Report to Congress on Abnormal Occurrences: Fiscal Year 2018 (← links)
- NUREG-1556 Volume 9, Rev. 3, Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses Final Report (← links)
- ML19270G979 (← links)
- ML19064A484 (← links)
- ML19322A311 (← links)
- ML19218A167 (← links)
- ML20009C049 (← links)
- ML19176A455 (← links)
- ML12164A733 (← links)
- ML20034E997 (← links)
- ML20056E123 (← links)
- ML20056D981 (← links)
- ML20137Z347 (← links)
- ML20137R118 (← links)
- ML20137D038 (← links)
- ML20137C307 (← links)
- ML20137C265 (← links)
- ML20136G543 (← links)
- ML20136D909 (← links)
- ML20136B882 (← links)
- IR 05000178/2038001 (← links)
- NUREG-0090 Volume 42, Report to Congress on Abnormal Occurrences, Fiscal Year 2019 (← links)
- ML20148Q722 (← links)
- ML20147J380 (← links)
- ML20147F149 (← links)
- ML20147D688 (← links)
- IR 05000176/1986001 (← links)
- ML20140F250 (← links)
- ML20140B107 (← links)
- ML20138G532 (← links)
- ML20129B462 (← links)
- ML20127F916 (← links)
- ML20127D359 (← links)
- ML20127C403 (← links)
- ML20127A686 (← links)
- ML20126C232 (← links)
- IA-85-130, Responds to FOIA Request for License Application for Mallinckrodt Radiopharmacies in Philadelphia,Pa,Pittsburgh, Pa,St Louis,Mo & Cleveland,Oh.Documents Available in Pdr. Documents 24 & 25 Partially Withheld (Ref FOIA Exemption 6) (← links)
- IA-92-416, List of Records Re Cleveland Clinic Foundation Produced by NRC Nudocs for NRC (← links)
- ML20163A634 (← links)
- ML20268A919 (← links)
- ML20255A129 (← links)
- IA-88-261, Final Response to FOIA Request for Documents.Forwards App a Documents.Documents Available in PDR (← links)
- ML20154J876 (← links)
- ML20151F512 (← links)
- ML20151B335 (← links)
- ML20149E353 (← links)
- ML20149D805 (← links)
- ML20195J220 (← links)
- ML20155J436 (← links)
- ML20155B913 (← links)
- ML20155B894 (← links)
- ML20289A789 (← links)
- ML20199C743 (← links)
- ML20198K638 (← links)
- ML20198J932 (← links)
- ML20198J869 (← links)
- ML20198J830 (← links)
- ML20198J766 (← links)
- ML20198J418 (← links)
- ML20198J404 (← links)
- ML20198J188 (← links)
- ML20198J119 (← links)
- ML20198H887 (← links)
- ML20198H875 (← links)
- ML20198H830 (← links)
- IA-88-494, Final Response to FOIA Request for Documents.Forwards Partially Withheld App a Document (Ref FOIA Exemption 5) (← links)
- ML20206D709 (← links)
- ML20205H722 (← links)
- ML20205E374 (← links)
- ML20203C769 (← links)
- ML20202D386 (← links)
- ML20207M753 (← links)
- ML20207K360 (← links)
- IA-88-309, Recommends Commission Approval of Recommendations on Issue Issue of Whether NRC Should Seek Legislative Authority to Regulate Naturally Occurring & accelerator-produced Radioactive Matls (← links)
- ML20207A797 (← links)
- ML20206M705 (← links)
- ML20206L844 (← links)
- ML20206L840 (← links)
- ML20281A519 (← links)
- ML20209E066 (← links)
- ML20214Q559 (← links)
- ML20214K944 (← links)
- ML20214H652 (← links)
- ML20213F765 (← links)
- ML20212D594 (← links)
- ML20323A164 (← links)
- NUREG-1556 Volume 20, Rev. 1, Consolidated Guidance About Materials Licenses: Guidance About Administrative Licensing Procedures Final Report (← links)
- ML20238E728 (← links)
- ML20338A535 (← links)
- ML20249B895 (← links)
- ML20248L971 (← links)
- ML20248F619 (← links)
- ML20247G920 (← links)
- ML20247D456 (← links)
- ML20246J645 (← links)
- ML20246E906 (← links)
- ML20236W536 (← links)
- ML20236U839 (← links)
- ML20236S376 (← links)
- ML20293A340 (← links)
- ML20287A265 (← links)
- ML20235D517 (← links)
- ML20217Q921 (← links)
- ML20217Q721 (← links)
- ML20217Q449 (← links)
- IA-98-125, Final Response to FOIA Request for Documents.Documents Listed in App a Encl & Being Made Available to Public in Entirety (← links)
- ML20217P716 (← links)
- ML20217P404 (← links)
- ML20217M952 (← links)
- ML20217A820 (← links)
- ML20217A783 (← links)
- ML20216C862 (← links)
- ML21026A136 (← links)
- ML20211K956 (← links)
- ML20211G300 (← links)
- NUREG-0090 Volume 43, Report to Congress on Abnormal Occurrences, Fiscal Year 2020 (← links)
- ML21134A082 (← links)
- ML21103A357 (← links)
- ML21180A432 (← links)
- ML21239A247 (← links)
- ML20211F012 (← links)
- ML20210N005 (← links)
- ML21350A064 (← links)
- ML22063A454 (← links)
- ML21215A335 (← links)
- ML22174A286 (← links)
- OI 1-2021-015, Cabell Huntington Hospital - NRC Inspection Report 03003370/2021001 and NRC Office of Investigations Report 1-2021-015 (← links)
- NUREG-0090 Volume 44, Report to Congress on Abnormal Occurrences Fiscal Year 2021 (← links)
- SECY-22-0046, SRM-SECY-22-0046: Enclosure 1 - Report to Congress on Abnormal Occurrences: Fiscal Year 2021 (← links)
- VR-SECY-22-0046, Report to Congress on Abnormal Occurrences: Fiscal Year 2021 (Hanson) (← links)
- ML22220A309 (← links)
- ML22161A536 (← links)
- ML22117A213 (← links)
- ML22117A207 (← links)
- ML22117A201 (← links)
- ML21125A110 (← links)
- ML20114E201 (← links)
- ML22280A002 (← links)
- ML22278A183 (← links)
- ML22243A238 (← links)
- ML22326A362 (← links)
- ML22306A059 (← links)
- ML22306A057 (← links)
- ML22306A056 (← links)
- ML23088A209 (← links)
- ML23024A256 (← links)
- NUREG-0090 Volume 45, Report to Congress on Abnormal Occurrences, Fiscal Year 2022 (← links)
- ML23156A127 (← links)
- ML23156A040 (← links)
- ML23153A038 (← links)
- ML23122A356 (← links)
- NUREG-0090, SECY-23-0019: Enclosure 1 - NUREG-0090, Volume 45, Report to Congress on Abnormal Occurrences Fiscal Year 2022 (← links)
- ML23269A235 (← links)
- ML23270A956 (← links)
- ML23179A172 (← links)
- 10 CFR 35 (← links)
- 10 CFR 35.1, Purpose and Scope (← links)
- 10 CFR 35.2, Definitions (← links)
- 10 CFR 35.5, Maintenance of Records (← links)
- 10 CFR 35.6, Provisions for the Protection of Human Research Subjects (← links)
- 10 CFR 35.7, Fda, Other Federal, and State Requirements (← links)
- 10 CFR 35.8, Information Collection Requirements: Omb Approval (← links)
- 10 CFR 35.10, Implementation (← links)
- 10 CFR 35.11, License Required (← links)
- 10 CFR 35.12, Application for License, Amendment, Or Renewal (← links)
- 10 CFR 35.13, License Amendments (← links)
- 10 CFR 35.14, Notifications (← links)
- 10 CFR 35.15, Exemptions Regarding Type a Specific Licenses of Broad Scope (← links)
- 10 CFR 35.18, License Issuance (← links)
- 10 CFR 35.19, Specific Exemptions (← links)
- 10 CFR 35.24, Authority and Responsibilities for the Radiation Protection Program (← links)
- 10 CFR 35.26, Radiation Protection Program Changes (← links)
- 10 CFR 35.27, Supervision (← links)
- 10 CFR 35.40, Written Directives (← links)
- 10 CFR 35.41, Procedures for Administrations Requiring a Written Directive (← links)
- 10 CFR 35.49, Suppliers for Sealed Sources Or Devices for Medical Use (← links)
- 10 CFR 35.50, Training for Radiation Safety Officer (← links)
- 10 CFR 35.51, Training for an Authorized Medical Physicist (← links)
- 10 CFR 35.55, Training for an Authorized Nuclear Pharmacist (← links)
- 10 CFR 35.57, Training for Experienced Radiation Safety Officer, Teletherapy Or Medical Physicist, Authorized Medical Physicist, Authorized User, Nuclear Pharmacist, and Authorized Nuclear Pharmacist (← links)
- 10 CFR 35.59, Recentness of Training (← links)
- 10 CFR 35.60, Possession, Use, and Calibration of Instruments Used to Measure the Activity of Unsealed Byproduct Material (← links)
- 10 CFR 35.61, Calibration of Survey Instruments (← links)
- 10 CFR 35.63, Determination of Dosages of Unsealed Byproduct Material for Medical Use (← links)
- 10 CFR 35.65, Authorization for Calibration, Transmission, and Reference Sources (← links)
- 10 CFR 35.67, Requirements for Possession of Sealed Sources and Brachytherapy Sources (← links)
- 10 CFR 35.69, Labeling of Vials and Syringes (← links)
- 10 CFR 35.70, Surveys of Ambient Radiation Exposure Rate (← links)
- 10 CFR 35.75, Release of Individuals Containing Unsealed Byproduct Material Or Implants Containing Byproduct Material (← links)
- 10 CFR 35.80, Provision of Mobile Medical Service (← links)
- 10 CFR 35.92, Decay-In-Storage (← links)
- 10 CFR 35.190, Training for Uptake, Dilution, and Excretion Studies (← links)
- 10 CFR 35.200, Use of Unsealed Byproduct Material for Imaging and Localization Studies for Which a Written Directive Is Not Required (← links)
- 10 CFR 35.204, Permissible Molybdenum-99, Strontium-82, and Strontium-85 Concentrations (← links)
- 10 CFR 35.290, Training for Imaging and Localization Studies (← links)
- 10 CFR 35.300, Use of Unsealed Byproduct Material for Which a Written Directive Is Required (← links)
- 10 CFR 35.310, Safety Instruction (← links)
- 10 CFR 35.315, Safety Precautions (← links)
- 10 CFR 35.390, Training for Use of Unsealed Byproduct Material for Which a Written Directive Is Required (← links)
- 10 CFR 35.392, Training for the Oral Administration of Sodium Iodide I-131 Requiring a Written Directive In Quantities Less Than Or Equal to 1.22 Gigabecquerels (33 Millicuries) (← links)
- 10 CFR 35.394, Training for the Oral Administration of Sodium Iodide I-131 Requiring a Written Directive In Quantities Greater Than 1.22 Gigabecquerels (33 Millicuries) (← links)
- 10 CFR 35.400, Use of Sources for Manual Brachytherapy (← links)
- 10 CFR 35.404, Surveys After Source Implant and Removal (← links)
- 10 CFR 35.406, Brachytherapy Sources Accountability (← links)